Most people say the vaccine symptoms were 'short-lived' and resolved themselves within eight days of the jab being administered. 9News
Those are the findings of a new study by AusVaxSafety, published in the Medical Journal of Australia, which surveyed more than three million Aussies after they were vaccinated.
The second Pfizer dose and the first AstraZeneca dose were the doses who made most Australians feel unwell in the days after the injections, the study found.Almost 55 per cent of people who had Pfizer reported a reaction after the second dose, while only 36 per cent had a reaction to the first dose. Almost 53 per cent of people who had AstraZeneca reported a reaction after the first dose, and only 22 per cent reported one after the second dose.Most people said the symptoms were "short-lived" and resolved themselves within eight days of the vaccine being administered.
Only 0.9 per cent of people sought medical advice in the three days following vaccination, the study found. Researchers also found that adverse events were more frequently reported by people with underlying medical conditions, including a history of anaphylaxis.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
'Pandemic isn't over': PM urges Australians aged 30 and over to get fourth COVID-19 jabAuthorities expanded eligibility for the fourth COVID-19 jab, with those aged 30 and over eligible to receive the dose from Monday.
Read more »
More Australians eligible for COVID-19 antiviral treatmentThe drugs will be available to everyone aged over 70 and those over 50 who have health conditions such as obesity or diabetes. 9News
Read more »
More Australians eligible for COVID-19 antiviral treatmentThe drugs will be available to everyone aged over 70 and those over 50 who have health conditions such as obesity or diabetes. 9News
Read more »
More Australians eligible for COVID-19 antiviral treatmentYOUR SAY: Would you take an antiviral COVID-19 drug? An antiviral COVID-19 pill will become available tomorrow to everyone aged over 70 and those over 50 with health conditions in a bid to stem hospitalisations. 9News MORE:
Read more »
More Australians eligible for COVID-19 antiviral treatmentMillions more Australians will have access to life-saving antiviral COVID-19 treatment from tomorrow in a move to stem hospital admissions. 9News
Read more »
New COVID-19 jab rules to affect millions of AustraliansAn additional 7.5 million Australians are eligible for the fourth COVID-19 jab from today, sparking a surge in demand.
Read more »